FdaApplication

ANDA 210050

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2019-12-09

Products (4)

ProductActive ingredientStrengthDosage form
EVEROLIMUSEVEROLIMUS5MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS10MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS7.5MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS2.5MGTABLET;ORAL

4 products